Ranbaxy, Merck Discontinue Drug Discovery Pact
January 06, 2011 at 02:55 AM EST
BANGALORE -(Dow Jones)- Ranbaxy Laboratories Ltd. (500359.BY) has discontinued a drug discovery and clinical development collaboration with U.S.-based Merck & Co. Inc. (MRK), aimed at developing new anti-bacterial and anti-fungal drugs.
